Evidence map›Paper›PMID 39711533›Full record

ArticleResearch square2024

InTraSeq: A Multimodal Assay that Uncovers New Single-Cell Biology and Regulatory Mechanisms.

Sean Beausoleil, Majd Ariss, Linglin Huang, Xiaokai Ding, Shivani Sheth, Tyler Levy, Jeremy Fisher, Jean Loebelenz, Keith Arlotta, Karen Dixon and 2 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sean BeausoleilCell Signaling Technology, Inc., Danvers, Massachusetts, USA.ORCID 0000-0002-3356-4641
Majd ArissCell Signaling Technology, Inc., Danvers, Massachusetts, USA.
Linglin HuangThe Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Xiaokai DingThe Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-5844-5008
Shivani ShethCell Signaling Technology, Inc., Danvers, Massachusetts, USA.
Tyler LevyCell Signaling Technology, Inc., Danvers, Massachusetts, USA.
Jeremy FisherCell Signaling Technology, Inc., Danvers, Massachusetts, USA.ORCID 0000-0002-7296-586X
Jean LoebelenzCell Signaling Technology, Inc., Danvers, Massachusetts, USA.
Keith ArlottaCell Signaling Technology, Inc., Danvers, Massachusetts, USA.
Karen DixonThe Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-7811-5439
Roberto PolakiewiczCell Signaling Technology, Inc., Danvers, Massachusetts, USA.
Vijay KuchrooThe Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Funding

Role of Negative Costimulation in Regulation of AutoimmunityP01AI039671 · NIAID · YALE UNIVERSITY · PI David A. Hafler · 1996 to 2026
$51.7M
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral toleranceR01AI144166 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI VIJAY K. KUCHROO · 2020 to 2026
$3.2M
Neuroimmune interactions regulate development of allergic inflammationR01AI139536 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 2018 to 2022
$2.9M
Metabolic regulators of Treg/Th17 balance in CNS autoimmunityR01AI169075 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI VIJAY K. KUCHROO · 2022 to 2026
$2.8M
Role of metabolic crosstalk in determining immunity during tumor progressionR01CA282794 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ANA C ANDERSON, VIJAY K. KUCHROO · 2023 to 2026
$2.0M
Role of Tim-l in B Cells in regulating autoimmunity in the CNSR01AI185514 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI VIJAY K. KUCHROO · 2024 to 2026
$1.9M
NCI NIH HHS R01 CA282794NIAID NIH HHS P01 AI039671NIAID NIH HHS R01 AI139536NIAID NIH HHS R01 AI144166NIAID NIH HHS R01 AI169075NIAID NIH HHS R01 AI185514
6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) has revolutionized cell biology by enabling the profiling of transcriptomes at a single-cell resolution, leading to important discoveries that have advanced our understanding of cellular and tissue heterogeneity, developmental trajectories, and disease progression. Despite these important advances, scRNA-seq is limited to measuring the transcriptome providing a partial view of cellular function. To address this limitation, multimodal scRNA-seq assays have emerged, allowing for the simultaneous measurement of RNA expression and protein. Intracellular Transcriptomic and Protein Sequencing (InTraSeq), a novel multimodal scRNA-seq technology described here, enables the concurrent measurement of mRNA, surface markers, cytoplasmic proteins, and nuclear proteins within individual cells through oligo-barcoded antibodies. This method offers a comprehensive approach to studying cellular function by combining RNA and protein pro ling from the same sample and utilizing a relatively simple protocol. The InTraSeq method enables researchers to expand their view of critical intracellular protein expression including post-translational modifications (PTMs) and transcription factors, allowing for the identification of novel cellular subtypes and states that may be obscured by RNA-based analyses alone. This is particularly valuable in understanding the heterogeneity of cell populations and identifying distinct functional states. In this report, we used InTraSeq to characterize the complex cellular states and regulatory mechanisms during Th17 cell differentiation. We simultaneously pro led RNA and protein expression in over 85,000 cells, capturing transcriptional changes, changes in protein expression and the dynamics of signaling pathways at a high resolution. Our results revealed novel insights into Th17 cell differentiation, including the identification of key regulatory factors and their target genes. By simultaneously measuring mRNA, extra and intra-cellular proteins, signaling proteins, and PTMs, InTraSeq offers a comprehensive understanding of cellular processes and enables the identification of novel regulatory mechanisms.

Indexed as

intracellular proteinInTraSeqpost-translational modificationsignaling pathwaysingle-cell

Identifiers

PMID39711533
PMCPMC11661302

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.